Story perspectives

Zuckerberg and Chan Invest in AI for Disease Research

11/9/2025

50 6

Summary

Story summary

Dr. Priscilla Chan and Mark Zuckerberg shift their philanthropy to AI and science through Biohub, aiming to develop AI-based cell models to improve disease detection, prevention, and treatment.
This shift follows a decade of funding social initiatives, including education and immigration reform.
Biohub will expand computing capacity and has hired EvolutionaryScale to lead its AI research.
Their goal is to create virtual cell systems to advance biomedical research.

1 of 1

Story summary

Dr. Priscilla Chan and Mark Zuckerberg shift their philanthropy to AI and science through Biohub, aiming to develop AI-based cell models to improve disease detection, prevention, and treatment.
This shift follows a decade of funding social initiatives, including education and immigration reform.
Biohub will expand computing capacity and has hired EvolutionaryScale to lead its AI research.
Their goal is to create virtual cell systems to advance biomedical research.